PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Liver cancer: a promising avenue for more effective immunotherapies

A research team of Canadian and French scientists identifies biomarker that may explain treatment failure in some people

Liver cancer: a promising avenue for more effective immunotherapies
2024-02-14
(Press-News.org) Laval, February 14, 2024 – A research team of Canadian and French scientists, led by INRS professor Maya Saleh, has been investigating immunotherapy resistance in certain patients with hepatocellular carcinoma (HCC) associated with steatotic liver disease. The findings are published in the journal Cell Reports.

Hepatocellular carcinoma is associated with known risk factors such as chronic hepatitis B or C infection, alcohol abuse, and metabolic dysfunction. It is the most common type of liver cancer. Despite major advances in immunotherapy, this cancer is often fatal: around 75% of patients with advanced HCC fail to respond to this type of treatment, for reasons that had yet to be clarified.

This encouraged the research team to explore the link between metabolic dysfunction-associated liver disease, a chronic inflammatory disease of the liver, and therapeutic resistance to immunotherapy in HCC patients.

“We have identified an immune biomarker for HCC associated with stetatotic liver disease, which will allow us to develop new immunotherapies,” explains Professor Maya Saleh, an international specialist in immuno-oncology. “We could envisage immunotherapies that restore an effective immune response against HCC by attenuating the damaging liver inflammation.”

 

Discovery of a potential therapeutic target

HCC remains a major public health concern; in North America, its incidence has doubled in the past three decades. Prior to the approval of immunotherapy, the treatment options for advanced HCC were limited and ineffective. As an example, sorafenib improves mean overall survival by just 3 months and is associated with significant side effects.

 

Immunotherapies, when administered in combinations, increase the average survival of HCC patients by 17 months on average.

Thanks to the use of “omics” technologies, which allow large quantities of biological data to be analyzed in a short timeframe, the team developed an immune map of the tumour and adjacent non-tumoral liver in 10 patients. These initial immune maps led them to study databases of hundreds of patients in order to validate the immune profiles related to risk factors and associated with disease severity.

 

These initial results indicate that the chronic inflammation from steatotic liver disease makes the liver cancer environment unique, with an expansion of immunosuppressive cells that paralyse the immunological attack of the tumour.

 

The research team has demonstrated that the immunosuppressive cells express an inflammatory receptor, named TREM1, which makes them more dangerous. They therefore highlighted TREM1 as a potential therapeutic target in HCC associated with steatotic liver disease.

 

Interesting implications for immunotherapy research

By identifying this biomarker, which could explain treatment failure in people with HCC, the team has paved the way for a new approach to classifying patients. This would allow them to determine who would be more likely to respond to immunotherapy before treatment even begins.

 

Such a scientific breakthrough would ease the psychological burden for patients who don’t respond to immunotherapy. Important physical impacts, including side effects, could also be prevented.

 

“This is a promising avenue for the next few years. We will continue the analysis by characterizing the immune component of tumours in a larger cohort of patients, including comprehensive imaging of tumour cell composition and the use of artificial intelligence to link immune profiles to response to therapy. This could have a significant impact on the field,” concludes Professor Saleh.

 

About the study

 

This paper was co-authored by Julie Giraud, Domitille Chalopin, Eloïse Ramel, Thomas Boyer, Atika Zouine, Marie-Alix Derieppe, Nicolas Larmonier, Olivier Adotevi, Brigitte Le Bail, Jean-Frédéric Blanc, Christophe Laurent, Laurence Chiche, Marc Derive, Macha Nikolski, and Maya Saleh.

 

Entitled “THBS1+ myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1,” it was published in Cell Reports Vol 43, Issue 2. DOI: 10.1016/j.celrep.2024.11377.

 

This research was funded to Dr. Saleh by the Fondation ARC, IDEX Bordeaux, ITMO Cancer, the Nouvelle-Aquitaine region in France, and SIRIC BRIO.

 

 

About INRS 

 

INRS is an academic institution dedicated exclusively to graduate research and training. Since its creation in 1969, it has actively contributed to Quebec’s economic, social, and cultural development. INRS ranks first in Quebec and Canada in research intensity. It is made up of four interdisciplinary research and training centres located in Quebec City, Montreal, Laval, and Varennes, which focus their efforts on strategic sectors: water, earth, and environment (Eau Terre Environnement Research Centre); energy, materials, and telecommunications (Énergie Matériaux Télécommunications Research Centre); urbanization, culture, and society (Urbanisation Culture Société Research Centre); and health and biotechnology (Armand-Frappier Santé Biotechnologie Centre). The INRS community includes over 1,500 students, postdoctoral fellows, and faculty and staff members. 

 

-30-

For more information 

 

Julie Robert 

Communications and Public Affairs Department 

Institut national de la recherche scientifique 

medias@inrs.ca 

END


[Attachments] See images for this press release:
Liver cancer: a promising avenue for more effective immunotherapies Liver cancer: a promising avenue for more effective immunotherapies 2 Liver cancer: a promising avenue for more effective immunotherapies 3

ELSE PRESS RELEASES FROM THIS DATE:

The program of the 17th World Congress on Polyphenols Applications 2024 is now released: Advancing polyphenols research

The program of the 17th World Congress on Polyphenols Applications 2024 is now released: Advancing polyphenols research
2024-02-14
The 17th World Congress on Polyphenols Applications 2024, scheduled for September 19-20, 2024, at Università degli Studi di Milano Statale in Italy, has revealed its program. This congress aims to bridge the latest scientific research on polyphenols with their potential to promote health. Goals The Polyphenols Applications 2024 Congress aims to share novel insights into polyphenols and their impact on human health, with the goal of finding practical ways to enhance well-being. Highlighted Program Polyphenols in Health & Diseases: Understanding the effects of polyphenols on health. Polyphenols, Microbiota & ...

Join the World Mitochondria Society in Berlin for their 15th Annual Meeting: Emerging Trends & Strategies

Join the World Mitochondria Society in Berlin for their 15th Annual Meeting: Emerging Trends & Strategies
2024-02-14
The 15th World Congress on Targeting Mitochondria is set to take place in Berlin from October 28-30, 2024, promising a platform for front-line discussions and major insights into mitochondrial research. Prof. Volkmar Weissig, president of the World Mitochondria Society stated: "In this 15th edition, we'll explore the fundamental and mechanistic research of mitochondria. But what really sets this year apart is our special focus on how mitochondria can be applied in real-world medical settings. We'll be ...

Novel drug combination shows promise for advanced her2-negative breast cancer

Novel drug combination shows promise for advanced her2-negative breast cancer
2024-02-14
FOR IMMEDIATE RELEASE A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center. The treatment included a histone deacetylase (HDAC) inhibitor — a drug that causes a chemical change to stop tumor cells from dividing — with two types of immunotherapy known as checkpoint inhibitors, which unharness the power of the immune response against cancer.  The multicenter ...

Key genes linked to DNA damage and human disease uncovered

2024-02-14
More than one hundred key genes linked to DNA damage have been uncovered through systematic screening of nearly 1,000 genetically modified mouse lines, in a new study published today (14 February) in Nature. The work provides insights into cancer progression and neurodegenerative diseases as well as a potential therapeutic avenue in the form of a protein inhibitor. The genome contains all the genes and genetic material within an organism's cells. When the genome is stable, cells can accurately replicate and divide, passing on correct genetic ...

New study finds Black birthing people prefer Black obstetric providers due to experiences of discrimination and fear of dying during pregnancy or childbirth

2024-02-14
UNDER EMBARGO UNTIL:  Feb. 14, 2024, 11:45 AM EST Media Contacts: Karen Addis, APR, karen@addispr.com, +1 (301) 787-2394; Kerri Wade, MPA, kwade@smfm.org, +1 (202) 236-1780 National Harbor, Md. -- Data from the Centers for Disease Control and Prevention demonstrate that Black women in the United States are three times more likely to die from a pregnancy-related cause than are white women. Health disparities among people of color are the result of broader social and economic inequities rooted in racism and discrimination.  In a new study to be presented today at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting™, researchers ...

SLAS Life Sciences and Technology Awards announced

SLAS Life Sciences and Technology Awards announced
2024-02-14
Boston, MA (February 13, 2024) – Science and technology awards were announced during the SLAS2024 International Conference and Exhibition, the annual flagship event of the Society for Laboratory Automation and Screening, which attracted a record-setting 7500 attendees and 400 exhibitors. Each year SLAS recognizes several exceptional presenters and exhibitors who represent the best of the Society’s programs and mission. The complete list of the 2024 award descriptions and winners follow: SLAS Innovation Award The most ...

Is the Amazon forest approaching a tipping point?

2024-02-14
Global warming may be interacting with regional rainfall and deforestation to accelerate forest loss in the Amazon, pushing it towards partial or total collapse.  Research published today [14 February 2024] in Nature, has identified the potential thresholds of these stressors, showing where their combined effects could produce a ‘tipping point’ - in which the forest is so fragile that just a small disturbance could cause an abrupt shift in the state of the ecosystem.  The study was led by the Federal University ...

Cognitive symptoms of post–COVID-19 condition and daily functioning

2024-02-14
About The Study: The findings of this survey study of U.S. adults suggest that cognitive symptoms are common among individuals with post–COVID-19 condition and associated with greater self-reported functional impairment, lesser likelihood of full-time employment, and greater depressive symptom severity. Screening for and addressing cognitive symptoms is an important component of the public health response to post–COVID-19 condition.  Authors: Roy H. Perlis, M.D., M.Sc., of Massachusetts General Hospital in Boston, is the corresponding ...

Prescription opioid exposure during pregnancy and risk of spontaneous preterm delivery

2024-02-14
About The Study: In this study of 251,000 pregnant patients with Tennessee Medicaid and without opioid use disorder, a positive association was found between total prescription opioid dose dispensed and the odds of spontaneous preterm birth. These findings support guidance to minimize opioid exposure during pregnancy and prescribe the lowest dose necessary. Authors: Sarah S. Osmundson, M.D., M.S., of the Vanderbilt University Medical Center in Nashville, is the corresponding author.  To access the embargoed study: Visit our For The Media ...

Researchers characterize the immune landscape in cancer

Researchers characterize the immune landscape in cancer
2024-02-14
New York, NY [February 14, 2024]—Researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium of the National Institutes of Health, The University of Texas MD Anderson Cancer Center, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and others, have unveiled a detailed understanding of immune responses in cancer, marking a significant development in the field. The findings were published in the February ...

LAST 30 PRESS RELEASES:

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’

Condo-style living helps keep the peace inside these ant plants

Climate change action could dramatically limit rising UK heatwave deaths

Annual heat-related deaths projected to increase significantly due to climate and population change

Researchers discover new way cells protect themselves from damage

[Press-News.org] Liver cancer: a promising avenue for more effective immunotherapies
A research team of Canadian and French scientists identifies biomarker that may explain treatment failure in some people